Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Tetanus × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 537 Glioblastoma 519 Glioma 266 Central Nervous System Neoplasms 186 Neuroblastoma 161 Gliosarcoma 161 Astrocytoma 155 Oligodendroglioma 103 Carcinoma, Non-Small-Cell Lung 82 Medulloblastoma 72 Breast Neoplasms 67 Ependymoma 60 Meningioma 58 Sarcoma 55 Neoplasm Metastasis 49 Melanoma 48 Recurrence 47 Neoplasms 47 Lung Neoplasms 44 Neurofibromatosis 1 41 Rhabdomyosarcoma 36 Osteosarcoma 36 Meningeal Carcinomatosis 36 Wilms Tumor 32 Lymphoma, Non-Hodgkin 31 Pheochromocytoma 30 Neuroectodermal Tumors, Primitive, Peripheral 28 Paraganglioma 27 Sarcoma, Ewing 25 Neurofibroma, Plexiform 23

Interventions

sargramostim 1 Temozolomide 1 Granulocyte-Macrophage Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03927222 2024-04-08

I-ATTAC

Duke University

Phase 2 Terminated

6 enrolled 7 charts

Glioblastoma, Tetanus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡